Huntington's disease.
D000328:Adult; D002648:Child; D002707:Chlordiazepoxide / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D005260:Female; D005817:Genetic Counseling; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D008297:Male; D010546:Perphenazine / Q000627:therapeutic use; D011613:Psychotherapy; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use; D009435:Synaptic Transmission; D013747:Tetrabenazine / Q000627:therapeutic use
D046948:Secologanin Tryptamine Alkaloids; D002707:Chlordiazepoxide; D010546:Perphenazine; D006220:Haloperidol; D003975:Diazepam; D004298:Dopamine; D013747:Tetrabenazine